Enterovirus 68 risk factors: Difference between revisions
YazanDaaboul (talk | contribs) No edit summary |
YazanDaaboul (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Extremes of age, pulmonary comorbidities such as [[asthma]] and [[cystic fibrosis]], and other systemic | Extremes of age, pulmonary comorbidities such as [[asthma]] and [[cystic fibrosis]], and other systemic comorbidities are considered significant risk factors for developing worse clinical disease among patients with EV-D68. | ||
==Risk Factors== | ==Risk Factors== | ||
Revision as of 20:05, 11 September 2014
|
Enterovirus 68 Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Enterovirus 68 risk factors On the Web | |
|
American Roentgen Ray Society Images of Enterovirus 68 risk factors | |
|
Risk calculators and risk factors for Enterovirus 68 risk factors | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]; Alejandro Lemor, M.D. [3]
Overview
Extremes of age, pulmonary comorbidities such as asthma and cystic fibrosis, and other systemic comorbidities are considered significant risk factors for developing worse clinical disease among patients with EV-D68.
Risk Factors
Patient age
- All patient populations are susceptible to EV-D68 infection. However, extremes of age is considered an important risk factor for worse clinical disease.
- Younger children, who lack previous immunity against the virus, and elderly patients, who have a decreased immune response, are more likely to develop worse disease manifestations [1]
- Immunocompromised patients have an increased risk of developing disease manifestations when exposed to EV-D68.
Pulmonary Comorbidities
Patients with pulmonary comorbidities are susceptible to severe lower respiratory tract disease when infected with EV-D68. Presence of pulmonary co-morbidities is associated with more admissions to the intensive care unit, need for mechanical ventilation, and death due to the infection. The most common pulmonary co-morbidities desribed in the literature include the following[2]:
- Asthma
- Cystic fibrosis
- Chronic pulmonary disease requiring home oxygen supplementation
- Lung transplantation
Systemic Comorbidities
Advanced systemic diseases not related to the respiratory system, such as hepatic cirrhosis, are also considered a risk factor for worse outcome in EV-D68 infections.
References
- ↑ "Enterovirus D68".
- ↑ Hasegawa, S.; Hirano, R.; Okamoto-Nakagawa, R.; Ichiyama, T.; Shirabe, K. (2011). "Enterovirus 68 infection in children with asthma attacks: virus-induced asthma in Japanese children". Allergy. 66 (12): 1618–1620. doi:10.1111/j.1398-9995.2011.02725.x. ISSN 0105-4538.